| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.057 | 0.3 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.061 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.033 | 0.6 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.027 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.017 | 0.7 |